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74 
 Region-specific impairment of the cervical spinal cord (SC) in amyotrophic 75 
lateral sclerosis: a preliminary study using SC templates and quantitative MRI 76 
(DTI/ihMT).  77 
In this preliminary study, our objective was to investigate the potentiality of high-resolution 78 
anatomical imaging, Diffusion Tensor Imaging and conventional/inhomogeneous Magnetization 79 
Transfer imaging (MT/ihMT) at 3T analyzed with template-extracted regions of interest to measure 80 
the atrophy and the structural changes of white and gray matter spinal cord (SC) occurring in ALS 81 
patients. 82 
Ten ALS patients and 20 age-matched healthy controls were recruited. SC gray matter (GM) and 83 
white matter (WM) areas were automatically segmented using dedicated templates. Atrophy indices 84 
were evaluated from T2*-weighted images at each vertebral level from cervical C1 to C6. DTI and 85 
ihMT metrics were quantified within the corticospinal tracts (CST), the posterior sensory tracts 86 
(PST) and the anterior GM horns (aGM) at C2 and C5 levels. Clinical disabilities of ALS patients 87 
were evaluated using Revised ALS Functional Rating Scale, Upper Motor Neuron (UMN) and 88 
Medical Research Council scorings and correlated to MR metrics. 89 
Compared to healthy controls, GM and WM atrophies were observed in ALS patients, especially at 90 
lower cervical levels, where a strong correlation was additionally observed between GM atrophy 91 
and the UMN score (R=-0.75, p=0.05 at C6). Interestingly, significant decrease of ihMT ratios was 92 
found in all the regions of interest (p-values<0.0008), FA and MT ratios significantly decreased in 93 
CST especially at C5 (p-values<0.005) and // significantly decreased in CST (p=0.0004) and PST 94 
(p=0.003) at C2. Strong correlations between MRI metrics and clinical scores were also found 95 
(0.47<|R|<0.87, p-values<0.05).  96 
Altogether, these preliminary results suggest that high-resolution anatomical imaging and ihMT 97 
imaging, in addition to DTI, are valuable to characterize SC tissue impairment in ALS. In this study, 98 
in addition to an important SC WM demyelination, we also observed for the first time in ALS 99 
impairments of cervical anterior GM. 100 
 101 
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Abbreviations 106 
(a)GM (Anterior) Gray Matter 
ADC Apparent Diffusion Coefficient 
ALS Amyotrophic Lateral Sclerosis 
ALSFRS-R Revised Amyotrophic Lateral Sclerosis Functional Rating Scale 
ANOVA Analysis of Variance 
CSA Cross-sectional area 
CSF Cerebrospinal Fluid 
CST Corticospinal tract 
DPR Disease Progression Rate 
DTI Diffusion Tensor Imaging 
ECG Electrocardiogram 
FA Fractional anisotropy 
FOV Field of view  
HASTE Half-Fourier acquired single-shot turbo spin echo 
ihMT(R) Inhomogeneous Magnetization Transfer (Ratio) 
LMN Lower Motor Neuron 
 Mp- Multi-parametric  
MR(I) Magnetic Resonance (Imaging) 
MRC Medical Research Council 
MT(R) Magnetization Transfer (Ratio) 
PST Posterior Sensitive tract 
RF Radiofrequency 
ROI Region of Interest 
SC Spinal Cord 
SE-EPI Spin-echo Echo-Planar Imaging 
STD Standard deviation 
UMN Upper Motor Neuron 
WM White Matter 
// Axial diffusivity 
 Radial diffusivity 
 107 
Introduction 108 
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease affecting both upper and 109 
lower motor neurons (UMN and LMN, respectively), which leads to progressive muscle weakness, 110 
physical disability, and eventual death within 1 to 10 years from symptom onset with a mean 111 
survival of 3 years
1,2
.11/20/2019 10:31:00 AM Given this marked heterogeneity of the disease, 112 
there is an unmet need for diagnostic, prognostic and monitoring biomarkers that could improve our 113 
understanding of ALS physiopathology. Such indicators have already been the subject of important 114 
investigations in both animal and human studies using a wide variety of techniques including 115 
electrophysiology, serology, as well as postmortem and in vivo Magnetic Resonance Imaging 116 
(MRI), and evidence of progressive damages of the corticospinal tracts (CST), involvement of 117 
sensory pathways
3–5
 , and presence of gray matter (GM) atrophy and degeneration
6,7
 have thereby 118 
been reported. In vivo MRI bears particularly great potential to investigate the pathology. Numerous 119 
studies have hence been conducted on the brain
8
, however only a few focused on the SC so far, 120 
mostly due to technical challenges related to small diameter, physiological motions and 121 
susceptibility artifacts
9,10
.  122 
Thanks to recent improvements including data sampling strategies or triggering method
11,12
, cord 123 
MRI can now indirectly help probing abnormalities in spinal GM motor neurons. Correlations 124 
between cord atrophy and hand muscle deficit have for instance been reported
5
. Cord MRI also 125 
helps characterizing impairment of white matter (WM) pathways. Degeneration of CST but also 126 
posterior sensory tracts (PST) have notably been detected using Diffusion Tensor Imaging (DTI) 127 
and Magnetization Transfer (MT)
4,5,13,14
.  128 
To go further, we now propose to specifically target GM atrophy and WM demyelination and see 129 
whether this could impact our knowledge on ALS disease. More precisely, given the relatively 130 
insufficient specificity of both DTI and conventional MT techniques to identify different 131 
pathophysiological mechanisms
15–17
, our aim here is to combine them with high-resolution 132 
anatomical imaging and the emerging inhomogeneous MT technique (ihMT)
18,19
. 133 
Indeed, DTI has largely been used to quantitatively assess structural changes in both brain and SC 134 
WM. DTI metrics, especially axial and radial diffusivities (    and    respectively) are now 135 
extensively used to evaluate axonal degeneration and demyelination in several pathologies 136 
involving the SC
12
. However, changes in DTI metrics could reflect various pathological 137 
mechanisms such as inflammation, edema, demyelination or axonal degeneration, hence limiting 138 
the specificity of the technique
11
. In the same way, MT has also largely been used and the derived 139 
MT metric (Magnetization transfer ratio or MTR) has proven to be highly sensitive to 140 
 microstructural tissue changes, especially to myelin alterations
5,20,21
. MT has however been reported 141 
having specificity limitation towards myelin, being sensitive to all the macromolecular pool and not 142 
only to myelinated structures. On the other hand, the recently proposed inhomogeneous MT 143 
technique bears great potential for myelin specific imaging. This new contrast mechanism has been 144 
interpreted as a dipolar order effect within the macromolecular pool which is characterized by a 145 
relaxation time constant T1D
22
. The ihMT technique provides a new mean to enhance the selectivity 146 
of MRI by properly weighting the signal to specific T1D range. Hence, thanks to its long T1D
23,24
 the 147 
dipolar order contribution of the myelinated structures can be isolated from the broad MT signal, 148 
giving rise to an enhanced myelinated tissue contrast as compared to conventional MT
19,25
. 149 
Although extensive work is still on-going for the full characterization of this technique
24,26
, it has 150 
already been used to assess brain and SC tissue demyelination in normal aging and multiple 151 
sclerosis
27,28
. Never applied in ALS so far, it could bring new insights into the pathophysiology of 152 
ALS.               153 
As for the resolution, most SC studies have so far focused on the characterization of the whole cord 154 
itself rather than its substructures, mostly due to the low spatial resolution of conventional clinical 155 
images with regards to the small SC cross-sectional dimensions. Over the last few years, high-156 
resolution anatomical imaging has been used to derive morphometric analyses in both WM and GM 157 
separately, allowing for instance studying GM atrophy occurring with age
28,29
. High-resolution 158 
anatomical imaging hence also offers great potential to distinctively assess GM and WM 159 
impairments in ALS.  160 
In this context, by using a multi-parametric (mp-) MR protocol combining DTI, ihMT and high-161 
resolution anatomical imaging along with SC templates and clinical evaluation, this preliminary and 162 
pilot study aimed to separately evaluate GM and WM atrophy at the cervical spine level, to assess 163 
structural changes occurring within specific SC regions of interest (ROIs) and ultimately, to provide 164 
new biomarkers and insights useful for the study of ALS disease mechanisms. 165 
 166 
Material and methods 167 
Subjects 168 
Ten patients (8 men, 2 women, age: 55.69.0 years old, ranging from 40 to 70) diagnosed with 169 
probable or definite ALS with spinal-onset according to the Awaji criteria
30
 and 20 age-matched 170 
healthy control (HC) subjects (10 men, 10 women, age: 53.810.0 years old, ranging from 39 to 74) 171 
were included. The local institutional ethics review board approved the study and written informed 172 
consent was obtained from all subjects before participation. Exclusion criteria were history of 173 
cervical trauma and acute medical condition.  174 
Clinical Assessment 175 
All patients underwent clinical examination before MR scanning (Table 1). Motor disability was 176 
evaluated using the revised ALS Functional Rating Scale (ALSFRS-R) (normal value, 48; 177 
minimum, 0)
31
, from which the disease progression rate (DPR) was derived such that DPR (in 178 
months 
-1
) =(48-ALSFRS-R)/disease duration (in months). By removing bulbar-related sub-score 179 
(normal value: 12; minimum 0) from total ALSFRS-R, Spinal ALSFRS-R sub-score (normal value: 180 
36; minimum 0) was extracted. An adapted Upper Motor Neuron score (UMN)
32
, grading limb 181 
tendon and jaw jerk reflexes, as well as Hoffman and Babinski signs, was also evaluated (normal 182 
value, 24 to 34; maximum: 55).  183 
Muscle strength in the upper limbs was measured in 14 muscles (7 on each side) using the Medical 184 
Research Council (MRC)
32,33
 rating scale (normal value per muscle, 5; range, [0 - 5]). Hand Grip 185 
strength was measured to evaluate upper limb muscle deficits using the Martin Vigorimeter (Martin 186 
Medizintechnik, Tuttlingen, Germany)
34,35
.  187 
MR Imaging and preprocessing 188 
 MR acquisitions were performed on a 3T-MRI (MAGNETOM Verio; Siemens Healthcare, 189 
Erlangen, Germany) using the body coil for transmission, and the standard 12-channel head, 4-190 
channel neck and 24-channel spine matrix array coils for reception. The MR protocol, including 191 
anatomical, DTI and ihMT acquisitions (cf. Table 2 for general sequence parameters), was 192 
optimized to last about one hour to minimize patient discomfort.  193 
Anatomical imaging included one sagittal 3D T2-weighted turbo spin-echo (TSE) sequence 194 
covering the entire cervical spinal cord from cervical level C1 to C7 and two axial 2D T2*-weighted 195 
multi-echo gradient echo sequences (Multi-Echo Data Image Combination, MEDIC) providing 196 
good WM and GM contrast. One slab (9 slices) was centered and optimized to be strictly 197 
perpendicular to the SC axis at mid-C2 (covering from C1 to C3) and the other one centered at mid-198 
C5 (covering from C4 to C6-C7). 199 
 200 
Diffusion Tensor Imaging (DTI) consisted in two axial slabs acquired using a monopolar single-201 
shot spin-echo echo-planar imaging (SE-EPI) prototype sequence (ECG-gating
36
, trigger delay 202 
300ms, TR ~ 2500ms (3 heart beats), fat saturation, 4 averages), placed perpendicularly to the SC 203 
axis: one was positioned mid-vertebrae at C2 level and the other one at C5 level. Local B0 204 
shimming was performed prior to the acquisition. Diffusion parameters were 30 independent 205 
diffusion-encoding directions, 2 b-values (0 and 800s/mm
2
), and / 15.42/34.24 ms.  206 
For each acquisition, in-line correction of eddy-current-induced distortions was performed using 207 
dynamic field correction
37
. The DTI metrics (Fractional Anisotropy (FA); Apparent Diffusion 208 
Coefficient (ADC); Radial diffusivity (); Axial diffusivity ()) were calculated online using 209 
Siemens Neuro 3D software.  210 
 211 
Classic and inhomogeneous Magnetization transfer (MT/ihMT) imaging was similarly performed 212 
at C2 and C5 levels with a customized pulsed saturation preparation optimized from
19
, (Hann-213 
shaped pulses lasting 0.5ms each, repeated every 1ms for a total saturation duration of 500ms, 214 
alternating single- and dual-frequency with a f=7kHz saturation offset, for a 4.9µT root-mean-215 
square B1 calculated over the whole saturation duration, hence delivering a total energy of 216 
12.1T2.s) using a single-slice half-Fourier acquired single-shot turbo spin echo (HASTE) readout. 217 
At each level, 4 unsaturated images (M0) along with 4 repetitions of 30 interleaved images per 218 
saturation scheme were acquired (124 images per time series in total). ECG data were recorded for 219 
retrospective correction of cerebrospinal fluid pulsatility-induced artifact as described in
19
.  220 
MT/ihMT ratios (MTR/ihMTR) were subsequently reconstructed using Matlab scripts (MATLAB 221 
R2012a, Mathworks, Natick, MA, USA), according to: 222 
                        (Eq. 1) 223 
                                              (Eq. 2) 224 
Where       and       correspond to a single offset saturation performed at positive and 225 
negative offset respectively;         and         correspond to dual offset saturations. 226 
Post-processing 227 
For each subject, individual anatomical T2*-weighted and multi-parametric MR data were first co-228 
registered. The sagittal 3D T2-w volume was then automatically segmented using PropSeg
38
 and 229 
non-linearly registered to the MNI-Poly-AMU template
39
 so as to provide an automated vertebral 230 
labeling of each subject scan. Then, for each level, automatic spinal cord segmentation and ROI 231 
delimitation based on the T2*-w images were performed using the probabilistic WM/GM AMU40
40
 232 
and WM tracts
41
 atlases, as summarized in Figure 1 and previously described in 
28
. The whole 233 
processing was performed using a customized MATLAB (MATLAB R2012a, Mathworks, Natick, 234 
MA, USA) script based on functionalities included in the SC Toolbox
42
.  235 
After post-processing, the dataset for each subject consisted of 4 DTI metrics and 2 MT metrics 236 
extracted from the bilateral CST, PST, and anterior GM (aGM) horns at C2 and C5 levels. Total 237 
GM was not considered for mp-MRI quantification due to potential partial volume effect. AMU40-238 
 based GM/WM segmentations were systematically visually checked, and when needed, manually 239 
adjusted (19 % of the data). Then, Cross-Sectional Areas (CSA), in mm
2
, were extracted from the 240 
segmentations. Mean values for each vertebral level (identified by registration to the MNI-Poly-241 
AMU template) were obtained by averaging values from all corresponding slices. Finally, SC CSA 242 
was obtained by computing the sum of GM and WM CSAs at each level (C7, which was not 243 
systematically included within the slab, was not considered).  244 
Statistical Analysis 245 
Univariate statistical analyses were performed using JMP9 (SAS institute, Cary, NC, USA). CSA 246 
from ALS patients and HC were compared in both GM and WM using two-way analyses of 247 
variance (ANOVA) with age as covariate. Similarly, differences of DTI and MT/ihMT metrics 248 
between the two groups (ALS and HC) were also assessed at each cervical level, within CST, PST 249 
and aGM, as well as in the whole WM. P-values are reported without correction for multiple 250 
comparisons such that *p<0.05, **p<0.005 and ***p<0.0005. Comparisons that survive 251 
Bonferroni correction for multiple comparisons with a threshold of p<0.05 are marked with () in 252 
the figures and tables.  253 
Correlations between MR metrics and clinical disability scores (total ALSFRS-R, spinal ALSFRS-254 
R, DPR, disease duration, UMN score, MRC scale, Hand Grip Strength) were assessed using 255 
Spearman rank test.  256 
Results 257 
Cross-sectional areas.  258 
Figure 2 shows representative WM/GM segmentations obtained at C2 and C5 for a HC and an age-259 
matched ALS patient. Figure 3 shows WM/GM CSA group analyses between controls and patients 260 
at each cervical level from C1 to C6. No age-related variations were found when performing the 261 
two-way ANOVA. As compared to HC, patients presented significantly lower GM CSA values 262 
(CSA28 mm2, dropout rate up to 37%, ***) in lower cervical levels (C4-C6). Significantly 263 
decreased WM CSA values (***) were also observed along the whole cervical SC, with higher 264 
decrease percentage (-36% to -41%, CSA< 53mm
2
) at lower levels. As a consequence, whole SC 265 
CSA values were also significantly decreased in ALS patients (data not shown), the highest 266 
decrease being found at C4-C6 levels (-35% to -39%, CSA<63mm
2
).  267 
Regional multi-parametric MRI  268 
Characteristic mp-MRI maps collected in a HC subject and two age-matched ALS patients, one 269 
with moderate disease progression (ALS1, age=55, total ALSFRS-R=41, spinal ALSFRS-R=29, 270 
disease duration 41 months, DPR=0.17 months
-1
) and one with severe disease progression (ALS2, 271 
age=56, total ALSFRS-R=29, spinal ALSFRS-R=18, disease duration 17 months, DPR=2.71 272 
months
-1
) are shown in Figure 4. 273 
Metrics obtained for both populations in the different ROIs are summarized in Figure 5 (see also 274 
Supplementary Table 1 for a complete report of the results) and detailed below. According to the 275 
ANOVA, age did not influence any of the metric variations.  276 
a) Bilateral CST (Figure 5.A): in ALS patients, FA and ihMTR were found significantly lower 277 
as compared to controls (more than 12% and 17% of decrease, respectively).    was higher (up to 278 
+23%) although non-significantly different after correction for multiple correction. A moderate but 279 
significant decrease was also observed for MTR (-10% at C5) and    (-9% at C2).  280 
b) Bilateral PST (Figure 5.B): Similar variations although less pronounced and less significant 281 
than in the CST were observed for all metrics. A significant ihMTR decrease down to -15% was 282 
notably observed at C2 and down to -10% at C5 level. 283 
c) Whole WM (Figure 5.C): FA showed a significant decrease (down to -18% at C5),    a 284 
large and significant increase (more than +25%) whilst ADC increase was moderate but significant 285 
 at C5 after Bonferroni correction. More importantly, MTR and ihMTR were significantly decreased 286 
at both C2 and C5 levels (down to -25% and -15%, respectively). 287 
d) Anterior GM horns (Figure 5.D): In average, slightly but non-significantly increased ADC 288 
values (between +9% and +12%) in association with increase of both    and    were observed for 289 
the patients as compared to HC. A moderate decrease tendency of MTR values along with a 290 
significant decrease of ihMTR values (down to -12%) were also found at both C2 and C5 levels.  291 
Correlations with clinical scores  292 
Whole SC CSA was found significantly correlated to both total ALSFRS-R score (=0.63, p=0.05) 293 
and spinal ALSFRS-R sub-score (=0.64, p=0.05) (cf. Figure 6A) at C5, and a correlation tendency 294 
was observed at C6. Altogether, DTI and MT/ihMT metrics impairments were largely correlated to 295 
disease duration and MRC, especially at the C2 level in all regions. Complete correlation results are 296 
summarized in Supplementary Table 2. CST metrics at C2 (0.46≤||≤0.80) were more correlated to 297 
clinical scores than at C5 (0.49≤||≤0.61). MTR/ihMTR in aGM at both levels were more correlated 298 
to clinical scores than DTI metrics. Representative significant correlations are illustrated in Figure 299 
6B, C, and D.  300 
Discussion 301 
The main purpose of this study was to probe regional and microstructural changes of SC tissue 302 
occurring in ALS using a template-based analysis of multi-parametric MRI including high-303 
resolution anatomical imaging, DTI and conventional/inhomogeneous MT. Results showed 304 
evidences for: 1) WM and SC atrophy throughout the whole cervical segment and GM atrophy 305 
mainly at lower levels; 2) significant DTI and ihMT metrics variations compared to HC in the 306 
lateral CST, the PST and the aGM at both C2 and C5 cervical levels; 3) Correlations between MR 307 
metrics and clinical scores within the investigated ROIs.  308 
Spinal cord, Gray Matter and White Matter atrophies 309 
Most neuroimaging studies in ALS were conducted in the brain and showed evidence of GM and 310 
WM degeneration
6,8,43–49
. The few studies conducted so far in the cervical SC reported a reduction 311 
of cord CSA
5,21,43,50,51
, but they did not investigate GM/WM separately, probably due to insufficient 312 
GM/WM image contrast and low spatial resolution. In this study, thanks to the high GM/WM 313 
contrast and the higher resolution of our T2*-weighted images, we were able, not only to confirm 314 
the atrophy of cervical SC but also to quantify atrophy occurring in both GM and WM. 315 
GM atrophy has already been widely investigated in ALS at the brain level
6,7,52,53
 and reported to 316 
reflect degeneration of UMN. Similarly, the GM atrophy we found here probably reflects 317 
degeneration/destructuration of LMN as expected in ALS pathophysiology. Although no MR 318 
studies comparing the different forms of ALS (bulbar and spinal onset
3
) has yet been performed, the 319 
GM atrophy observed here is nonetheless highly consistent with the spinal-onset ALS form of our 320 
patients. As for WM atrophy, although WM loss have previously been reported by several studies 321 
conducted in the brain
54,55
, studies conducted in the spinal cord only reported WM tracts 322 
degeneration, particularly the CST
5,21,56,57
, but did not directly evaluate WM atrophy. In this study, 323 
based on automatic GM/WM segmentations of high-resolution anatomical T2*-weighted images, 324 
we were able to probe WM atrophy in ALS patients which could be explained by WM tracts 325 
degeneration as will be discussed in the next section. Further longitudinal assessment will provide 326 
more insights to these GM and WM atrophies and their temporal evolution patterns. 327 
ALS, a multi-system degenerative process 328 
CST degeneration in ALS has already been shown by numerous MR studies using various 329 
techniques including DTI and MT in both the brain
47,58,59
 and the SC
4,5,14,21,43
. Focusing on the 330 
spinal level, these studies reported reduced FA and increased    in the CST along the cervical 331 
SC
4,5,14
, as well as reduced MTR
5,21
 and non-significant ADC increase and    decrease. Our 332 
findings confirm these results and add further evidence of CST impairment from the ihMTR 333 
 significant decrease observed at both C2 and C5 cervical levels. FA,    and ADC changes may 334 
suggest axonal degeneration or destructuration, whereas the increase of    combined with 335 
decreased MTR and, more importantly with decreased ihMTR, the presumably myelin-specific 336 
contrast, suggest demyelination of the CST. Interestingly, ihMTR demonstrated the most significant 337 
variations as compared to the more conventional MTR and   . 338 
Although a moderate number of patients was included in this preliminary study, regression analyses 339 
showed significant correlations between FA,    and total ALSFRS-R, spinal ALSFRS-R, MRC and 340 
Hand Grip strength, at both C2 and C5 levels. Previous studies have reported correlations between 341 
disease severity and FA in the lateral CST
5,21
, but did not find any other significant correlations.    342 
ALS neurodegeneration is however not restricted to the primary motor system. Although less 343 
important and slower, it also extends to the sensory system as reported, not only in the brain
4,44,60
, 344 
but also in the SC by Cohen-Adad et al.
5
 and Iglesias et al.
4
. Both SC studies reported significant 345 
decrease of FA and increase of    while    showed no change in the dorsal columns. Moreover, 346 
Cohen-Adad et al. observed a decrease tendency of MTR values. In the present study, similar 347 
patterns of metric variations were observed in the PST with a trend for    increase and MTR 348 
decrease. Additionally, a significant ihMTR decrease was observed at both C2 and C5 levels, hence 349 
suggesting similar, although less pronounced, alterations in PST than in CST, in agreement with the 350 
two aforementioned studies reporting a less important impairment of sensory pathways than that of 351 
motor systems. Again, interestingly, ihMT variations were found more important and more 352 
significant than that of MTR and   . Results of preliminary correlation analyses between MR 353 
metrics and clinical score suggested degeneration/demyelination of PST as functional and muscular 354 
deficits get worse, also in line with the hypothesis of progressive sensory pathways degeneration 355 
observed by Iglesias et al
4
.  356 
Considering the whole cross-sectional WM, FA, MTR and ihMTR significantly decreased,    357 
significantly increased, and ADC tended to increase. To our knowledge, the present study is the 358 
first to investigate DTI and MT/ihMT metrics variations in the whole SC WM. The metric 359 
variations observed along with the tendency of correlation to clinical scores are in line with those 360 
measured in CST and PST taken separately, although the variation amplitude for all metrics in 361 
whole WM tended to be higher. One hypothesis for this tendency would be the alteration of other 362 
WM tracts such as anterior CST, rubrospinal or reticulospinal tracts. However, investigation of 363 
these latter was beyond the scope of this pilot study due to their small size (less than 10 pixels). 364 
Further studies with higher spatial resolution involving all WM tracts must thus be conducted to 365 
identify all the altered tracts.  366 
Even though ALS is primarily characterized by involvement of both UMN and LMN, assessing 367 
reliably with MRI the spinal anterior GM that contains the motor neurons of interest remains a 368 
challenge. Thanks to the highly contrasted and resolved T2*-w images and the automatic AMU40 369 
WM/GM segmentation and ROI delimitation used in this study, we successfully investigated in vivo 370 
spinal aGM degeneration with mp-MRI. Changes in ALS patients’ metrics were found: FA tended 371 
to decrease and ADC and    to increase, which could be explained by neuronal loss. MTR tended to 372 
decrease whilst ihMTR significantly did. GM oligodendroglial involvement in the SC has already 373 
been reported in in vitro and postmortem ALS studies
61,62
, and the ihMTR decrease observed here 374 
might thus suggest GM demyelination. As for now, the ihMTR values obtained here in GM should 375 
cautiously be interpreted as spatial blurring associated to the HASTE imaging readout might have 376 
slightly contaminated GM voxel with WM signals. Results obtained in aGM are nonetheless of 377 
particular interest for future explorations, and further studies using an alternative readout module 378 
will be conducted to minimize the potential WM signal contamination effect. Finally, when 379 
performing regression analyses, significant correlations between ihMTR and MTR and disease 380 
duration at both C2 and C5 levels, between ihMTR and MTR and spinal ALSFRS-R, MRC and 381 
Hand Grip strength at C2, and between    and MRC at C5 were found. Taken together with atrophy, 382 
these results suggest a more important neurodegeneration in lower cervical levels. This process 383 
 could be explained by the anatomical topography of motor neurons in the cervical SC described by 384 
Routal and Pal
63
, which suggest that spinal aGM horns at lower cervical levels contain numerous 385 
and thicker motor neuron groups as compared to upper cervical levels. These motor neurons could 386 
be involved in early stage of ALS neurodegeneration according to the four-stage model of ALS 387 
proposed by Braak et al.
64
. Further longitudinal follow-ups and multi-level investigations will be 388 
conducted to answer this specific question.  389 
Limitations and perspectives  390 
As aforementioned, we chose to limit the protocol to a one-hour acquisition time for the sake of 391 
patient comfort, hence precluding mp-MRI investigation of all cervical levels. To address this issue, 392 
further methodological developments are under consideration to allow for multi-slice and multi-393 
angle capability for both DTI and ihMT sequences, hence providing multiple pure cross-sectional 394 
SC slices within a single acquisition.  395 
Although challenging due to SNR loss, further developments towards a reduction of DTI and ihMT 396 
in-plane resolution (0.9x0.9 mm
2
) and slice thickness (10 mm) are also to be considered. Increasing 397 
the spatial in-plane resolution would allow exploration of the posterior GM horns, so far unexplored 398 
for mp-MRI due to GM-WM partial volume effect (PVE). Reducing the slice thickness may also 399 
help limiting PVE, even though through-slice morphological variation in the SC is expected to be 400 
small when the slice is positioned strictly perpendicular to the cord axis. It is worth noting that this 401 
choice of slice thickness (10 mm) was driven by the important need of SNR of the ihMT acquisition 402 
and was applied to DTI to ensure the same PVE-induced contamination. Current strategies 403 
developed to enhance the ihMT signal
26
 will greatly help to handle these issues in future studies.  404 
These sequence improvements along with longitudinal patients’ follow-ups will allow assessing 405 
both spatial and chronological progression of ALS. Additionally, further investigations on a larger 406 
cohort using a multivariate approach could lead to a better stratification of patients and finer 407 
characterization of SC degeneration. Furthermore, since some patients in this study showed 408 
asymmetric deficits when considering clinical scores (MRC score, Hand Grip strength) from left 409 
and right upper limbs, a careful investigation and correlation with mp-MRI metrics in lateralized 410 
ROIs, currently unavailable given the small cohort of patients, has to be performed in order to 411 
assess whether such asymmetry might also be observed in mp-MRI metrics variation. 412 
Finally, when considering DTI and MT/ihMT metrics, ihMTR decreases were found systematically 413 
more important and more statistically significant than DTI and conventional MT metrics variations 414 
within all ROIs, suggesting a marked sensitivity of the ihMT technique to tissue microstructural 415 
changes. This technique will therefore be of great interest when performing longitudinal follow-ups 416 
on ALS patients to monitor spatial and temporal tissue demyelination. Moreover, it would also offer 417 
great perspectives for investigating other demyelinating pathologies such as Multiple Sclerosis. In 418 
this context, it is worth noting that the ihMT contrast, which relies on dipolar mechanisms, is 419 
magnetic-field independent and has been previously applied at both 1.5T and 3T. Translation to 420 
higher field strengths (e.g. 7T) should be feasible in principle as long as the RF energy deposition is 421 
maintained within regulatory constraints. In this perspective, recent strategies aiming at reducing 422 
the RF demand to optimize the ihMT ratio are of great utility
26
. 423 
Despite some limitations, this pilot study combining high-resolution morphological and quantitative 424 
MRI showed great potential to investigate WM/GM tissue degeneration and demyelination, two 425 
major processes occurring in ALS. It more particularly suggests that: 1) spinal GM atrophy as 426 
measured using T2*-weighted-derived CSA may be a sensitive biomarker of anterior GM horn cell 427 
degeneration in ALS; and 2) DTI and MT metrics, especially ihMT ratio, may be sensitive and 428 
potentially early biomarkers of demyelination occurring in spinal cord WM; 3) multi-parametric 429 
MRI using different but complementary MR techniques may be a great tool for a finer and more 430 
exhaustive characterization of SC-involving pathologies.   431 
Conclusion 432 
 Thanks to dedicated template-based analysis, an efficient and reproducible way of extracting 433 
information from anatomical structures, and a mp-MRI protocol combining high-resolution 434 
anatomical imaging, DTI and the emerging myelin-specific inhomogeneous MT, we were able to 435 
probe evidences, for the first time, for both SC GM and WM atrophy in ALS. We also brought new 436 
elements clarifying the cervical GM horns degeneration, as well as corticospinal and posterior 437 
sensory tracts impairments.  438 
In addition to CST and PST destructuration/degeneration shown by DTI metrics and preliminary 439 
correlations with clinical scores, important demyelination has particularly been highlighted by 440 
ihMT ratio decrease. Moreover, direct evidence of anterior GM horns involvement has also been 441 
observed mostly through atrophy but also through ADC,    and ihMTR variations.  442 
Further longitudinal studies in a larger population and with refined MR sequences are to be 443 
conducted to investigate the prognostic role of GM atrophy and WM demyelination as markers of 444 
disease progression and to provide more insights to the pattern of degeneration and underlying 445 
processes involved in ALS pathophysiology. 446 
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Tables  685 
 Median Interquartile range Min - Max 
Disease duration (months) 15.5 [11-22] [7-53] 
Total ALSFRS-R (0-48) 41 [31-42] [29-44] 
Spinal ALSFRS-R sub-score 26.2 [20.2-31.9] [18-32] 
Disease progression rate 0.41 [0.28-1.06] [0.17-2.71] 
Total MRC Score (0-70) 58.5 [42-67] [19-70] 
Upper motor neuron score 40 [33-42] [30-47] 
Hand Grip strength (kPa) 27 [4-80] [0-100]; 
Table 1: Clinical features of the 10 ALS patients included in this study.  686 
 687 
688 
  689 
 DTI ihMT 2D T2*-w 3D T2-w 
Orientation / 
Readout 
(1)
 
Axial / Single Shot 
SE-EPI
 
 
Axial / HASTE Axial / MGE Sagittal / 
TSE 
TR (s)  
/ TE (ms) 
~2.5/79 ~4/TEeff=48 0.523/5 echoes, 
TEeff=27 
1.5/124 
Field of View  117x128mm
2
 172x172mm
2
 135x180mm
2
 256x256mm
2
 
Voxel size 0.9x0.9x10mm
3
 0.9x0.9x10mm
3
 0.47x0.47x5mm
3
 1x1x1mm
3
 
Location (spatial 
coverage) 
C2 (5 slices) 
C5 (5 slices) 
C2 (1 slice) 
C5 (1 slice) 
C1-C3 (9 slices) 
C4-C7 (9 slices) 
C1-C7 
Flip angle 90/180° 90/120° 28° 110° 
Parallel 
acquisition 
GRAPPA 
reconstruction (R=2) 
- GRAPPA 
reconstruction (R=2) 
- 
Phase-Encoding 
direction 
Right-Left Right-Left Anterior–Posterior Head-Feet 
Acquisition time 2x(~7min) 2x(~8min) 2x(3:44min) 5:53min 
Table 2:  Main MR parameters used in this study.  690 
(1)
 SE-EPI: Spin-Echo Echo-Planar Imaging; HASTE: Half-Fourier Acquired Single-shot Turbo 691 
spin-Echo; MGE: Multiecho Gradient Echo, TSE: Turbo Spin-Echo; GRAPPA: Generalized auto 692 
calibrating partially parallel acquisitions; CSF: Cerebrospinal Fluid. 693 
  
 
 
Supplementary Table 1: DTI and MT/ihMT metrics obtained for ALS and HC subjects in CST, PST, whole WM and anterior GM at both C2 and C5 levels. Values 
are mean ± standard deviation. P-values resulting from two-way analyses of variance are reported such as *p<0.05, **p<0.005, ***p<0.0005, uncorrected for 
multiple comparisons. () indicate statistical differences that survive Bonferroni correction for multiple comparisons.
  
Supplementary Table 2: Spearman’s coefficient correlations () between MRI metrics and clinical scores 
in ALS patients. Significant correlations are highlighted in bold and marked with * p<0.05, ** p<0.005, *** 
p<0.0005. 
 Figures 
Figure 1: Post-processing pipeline for MRI data, shown for C2 cervical level, and including spinal cord 
segmentation on T2*-w images, registration to the AMU40 template, GM/WM segmentations in the subject 
space followed by cross-sectional area extraction, as well as multi-parametric data intra-subject 
normalization allowing metrics extraction in whole WM, corticospinal tracts, posterior sensitive tracts and 
anterior GM horns. 
Figure 2: Gray and white matter atrophy in ALS patients.  
T2*-w images and representative GM/WM automatic segmentations (blue and yellow masks, respectively) 
extracted from a healthy control subject (top) and an age-matched ALS patient (bottom, ALSFRS-R=30, 
disease duration 16 months) at both C2 and C5 levels.  
Figure 3: Cross-sectional areas in mm
2
 in healthy controls and ALS patients. 
Mean values extracted from GM/WM segmentations in the subject spaces and averaged for each cervical 
level from C1 to C6. The boxplot bars represent from bottom to top: the intra-group outermost value that 
falls within the distance computed as 1
st
 quartile – 1.5*(3rd quartile – 1st quartile), the first quartile (25%), the 
median value, the third quartile (75%) and the outermost value computed as 3
rd
 quartile + 1.5*(3
rd
 quartile – 
1
st
 quartile), respectively for each cervical level; isolated markers are outliers. 
 CSA variation rate (%) between controls and patients for each level is calculated using the following 
formula: % = (CSApatients – CSAcontrols)/CSAcontrols, negative percentage indicating a decrease in patients’ 
values. P-values are reported as: *p<0.05 and ***p<0.0005, uncorrected for multiple comparisons. () 
indicate statistical differences that survive Bonferroni correction for multiple comparisons (adjusted 
Bonferroni p<0.0083).  
Figure 4: Representative multi-parametric maps at C2-level extracted from an age-matched healthy 
control subject (top) and two representative ALS patients: ALS1 (middle, ALSFRS-R=41, disease duration 
41 months) with moderately altered metrics and ALS2 (bottom, ALSFRS-R=29, disease duration 7 months) 
with severely altered metrics. 
Figure 5: DTI and MT/ihMT metrics obtained for ALS and HC subjects in (A) CST, (B) PST, (C) whole 
WM and (D) anterior GM at both C2 and C5 levels. Metrics variation rates (%) between ALS (in blue) and 
HC (in black) are indicated along with p-values (*p<0.05, **p<0.005, ***p<0.0005, uncorrected for multiple 
comparisons) resulting from two-way analyses of variance. () indicate statistical differences that survive 
Bonferroni correction for multiple comparisons. 
Figure 6: Representative correlations between MRI metrics and clinical scores in ALS patients. 
Correlation coefficients and p-values are derived from Spearman’s correlation. When existing, statistical 
level of significance is indicated as: *p<0.05, **p<0.005, ***p<0.0005. 
